Viscogel AB
🇸🇪Sweden
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2013-08-30
- Lead Sponsor
- Viscogel AB
- Target Recruit Count
- 130
- Registration Number
- NCT01578070
- Locations
- 🇸🇪
Karolinska Trial Alliance, Stockholm, Sweden
News
No news found